title: Purified eicosapentaenoic acid reduces small dense LDL, remnant lipoprotein particles, and C-reactive protein in metabolic syndrome.
authors.affiliation: Clinical Research Institute for Endocrine Metabolic Diseases, National Hospital Organization, Kyoto Medical Center, 1-1 Fukakusa Mukaihata-cho, Fushimi-ku, Kyoto 612-8555, Japan. nsato@kyotolan.hosp.go.jp
authors.forename: Noriko
authors.initials: N
authors.lastname: Satoh
authors.forename: Akira
authors.initials: A
authors.lastname: Shimatsu
authors.forename: Kazuhiko
authors.initials: K
authors.lastname: Kotani
authors.forename: Naoki
authors.initials: N
authors.lastname: Sakane
authors.forename: Kazunori
authors.initials: K
authors.lastname: Yamada
authors.forename: Takayoshi
authors.initials: T
authors.lastname: Suganami
authors.forename: Hideshi
authors.initials: H
authors.lastname: Kuzuya
authors.forename: Yoshihiro
authors.initials: Y
authors.lastname: Ogawa
mesh_terms: D016718:Arachidonic Acid / Q000097:blood; D015992:Body Mass Index; D002097:C-Reactive Protein / Q000187:drug effects / Q000378:metabolism*; D008076:Cholesterol, HDL / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood; D015118:Eicosapentaenoic Acid / Q000097:blood / Q000627:therapeutic use*; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D007328:Insulin / Q000097:blood; D008074:Lipoproteins / Q000097:blood* / Q000187:drug effects; D008077:Lipoproteins, LDL / Q000097:blood* / Q000187:drug effects; D024821:Metabolic Syndrome / Q000097:blood*; D009765:Obesity / Q000097:blood*
chemical_list: D016718:Arachidonic Acid; D002097:C-Reactive Protein; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D015118:Eicosapentaenoic Acid; D006442:Glycated Hemoglobin; D007328:Insulin; D008074:Lipoproteins; D008077:Lipoproteins, LDL